AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL INJURY AND HYPOXIA, REPRESENTING MAGNESIUM 2-AMINOETHANESULFONATE, PHARMACEUTICAL COMPOSITIONS

摘要

FIELD: medicine.;SUBSTANCE: what is presented is a therapeutic agent possessing neuroprotective action in ischemic cerebral injury and hypoxia, representing magnesium 2-aminoethanesulfonate (magnesium taurinate). It has been shown that magnesium taurinate possesses high neuroprotective action; therapeutic application of magnesium 2-aminoethanesulfonate 50 mg/kg in cerebral ischemia caused by one-side occlusion of a left carotid, and prevents the developing ischemic cerebral injuries more effectively than if applying Picamilonum. There are also presented: solid dosage pharmaceutical composition on the basis of this compound in the form of tablets, capsules, powders, and a pharmaceutical composition for injections.;EFFECT: neuroprotective properties enable the presented pharmaceutical compositions of magnesium taurinate suggested to be used for preventing and treating ischemic cerebral injures.;6 cl, 4 tbl